OR WAIT null SECS
April 02, 2016
Global outbreaks energize vaccine R&D and drive production modernization.
March 29, 2016
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
March 02, 2016
Asking the right questions is crucial to establishing a biopharmaceutical facility design.
January 06, 2016
Takeda Pharmaceuticals announced the acquisition of a biopharmaceuticals manufacturing plant in Minnesota.
December 21, 2015
Samsung BioLogics begins construction on their third facility in Songdo, Korea.
December 03, 2015
Seqirus, CSL Limited’s influenza vaccine business, announced the opening of their corporate headquarters in the United Kingdom.
December 02, 2015
FDA confirmed quality focus while Congress moved to bolster biomedical innovation.
November 05, 2015
Biotech boom, niche markets, smaller batch sizes and high potency manufacturing are among the key trends shaping the pharmaceutical industry of the 21st century, according to Christian Treitel from Bosch Packaging Technology.
South Africa’s Biovac Institute, which develops and produces vaccines for the country, launched a public-private partnership with Pfizer to enable local manufacturing of Prevenar 13, a vaccine against pneumonia-causing bacteria.
November 02, 2015
While biologics development grabs investor interest, small-molecule APIs still hold two-thirds of the drug-development pipeline.